Evidence map›Paper›PMID 42432134›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Downstream invasive coronary procedures following PET Versus SPECT myocardial perfusion imaging: a propensity-matched analysis.

Chadi Tabaja, Issam Motairek, Bryan Abadie, Laura Young, Venu Menon, Wael A Jaber

Abstract readComparative Study
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chadi TabajaDepartment of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.
Issam MotairekDepartment of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.
Bryan AbadieDepartment of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.
Laura YoungDepartment of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.
Venu MenonDepartment of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.
Wael A JaberDepartment of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA. JABERW@ccf.org.ORCID http://orcid.org/0000-0001-5642-2112

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

methodsWe performed a retrospective analysis using the TriNetX Research Network. Adults undergoing PET or SPECT MPI without prior coronary revascularization were identified. The primary endpoint was invasive coronary angiography (ICA) within 90 days, with percutaneous coronary intervention (PCI) as a secondary endpoint. Propensity score matching (1:1) was performed to adjust for baseline differences.

resultsA total of 33,822 propensity-matched patients were included (PET n=16,911; SPECT n=16,911). At 90 days, ICA occurred less frequently after PET compared with SPECT (6.0% vs 6.8%; RR 0.89, 95% CI 0.82-0.97; p=0.005). Conversely, PCI was more frequent following PET (0.9% vs 0.4%; RR 2.00, 95% CI 1.51-2.65; p<0.001), indicating a higher angiography-to-PCI procedural yield. These findings were consistent across sex-based subgroups.

conclusionIn a large real-world cohort, PET MPI was associated with fewer downstream invasive coronary angiograms and a higher procedural PCI yield compared with SPECT. These findings suggest that PET may improve selection of patients for invasive evaluation and enhance efficiency of downstream care.

Indexed as

Myocardial Perfusion ImagingPercutaneous Coronary InterventionPositron-Emission TomographyTomography, Emission-Computed, Single-PhotonAgedCoronary AngiographyFemaleHumansMaleMiddle AgedPropensity ScoreRetrospective Studies

Identifiers

PMID42432134
PMCPMC13633369

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.